These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3552712)

  • 61. Quantification of Histidine-Rich Protein 3 of Plasmodium falciparum.
    Palani B
    Monoclon Antib Immunodiagn Immunother; 2018 Apr; 37(2):87-90. PubMed ID: 29634395
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Selection of an adjuvant for vaccination with the malaria antigen, MSA-2.
    Pye D; Vandenberg KL; Dyer SL; Irving DO; Goss NH; Woodrow GC; Saul A; Alving CR; Richards RL; Ballou WR; Wu MJ; Skoff K; Anders RF
    Vaccine; 1997 Jun; 15(9):1017-23. PubMed ID: 9261951
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Field evaluation of an enzyme-linked immunosorbent assay (ELISA) for Plasmodium falciparum sporozoite detection in anopheline mosquitoes from Kenya.
    Beier JC; Perkins PV; Wirtz RA; Whitmire RE; Mugambi M; Hockmeyer WT
    Am J Trop Med Hyg; 1987 May; 36(3):459-68. PubMed ID: 3555134
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Comparison of antibody avidity and titre elicited by peptide as a protein conjugate or as expressed in vaccinia.
    Lew AM; Anders RF; Edwards SJ; Langford CJ
    Immunology; 1988 Oct; 65(2):311-4. PubMed ID: 3056855
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cellular and humoral immune responses to a recombinant P. falciparum CS protein in sporozoite-immunized rodents and human volunteers.
    Nardin EH; Nussenzweig RS; Altszuler R; Herrington D; Levine M; Murphy J; Davis J; Bathurst I; Barr P; Romero P
    Bull World Health Organ; 1990; 68 Suppl(Suppl):85-7. PubMed ID: 2094595
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Structural basis for antibody recognition of the NANP repeats in
    Oyen D; Torres JL; Wille-Reece U; Ockenhouse CF; Emerling D; Glanville J; Volkmuth W; Flores-Garcia Y; Zavala F; Ward AB; King CR; Wilson IA
    Proc Natl Acad Sci U S A; 2017 Nov; 114(48):E10438-E10445. PubMed ID: 29138320
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Binding of malaria T cell epitopes to DR and DQ molecules in vitro correlates with immunogenicity in vivo: identification of a universal T cell epitope in the Plasmodium falciparum circumsporozoite protein.
    Calvo-Calle JM; Hammer J; Sinigaglia F; Clavijo P; Moya-Castro ZR; Nardin EH
    J Immunol; 1997 Aug; 159(3):1362-73. PubMed ID: 9233633
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Development, characterization and immunogenicity of a multi-stage, multi-valent Plasmodium falciparum vaccine antigen (FALVAC-1A) expressed in Escherichia coli.
    Zhou Z; Todd CW; Wohlhueter RM; Price A; Xiao L; Schnake P; Bonner PC; Martin AM; Goldman IF; De La Vega P; Udhayakumar V; Lal AA
    Hum Vaccin; 2006; 2(1):14-23. PubMed ID: 17012909
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Development of a sporozoite malaria vaccine.
    Nussenzweig V; Nussenzweig RS
    Am J Trop Med Hyg; 1986 Jul; 35(4):678-88. PubMed ID: 2425647
    [No Abstract]   [Full Text] [Related]  

  • 70. Plasmodium falciparum: induction of biologically active antibodies to gp195 is dependent on the choice of adjuvants.
    Hui GS; Chang SP
    Exp Parasitol; 1992 Aug; 75(1):155-7. PubMed ID: 1639161
    [No Abstract]   [Full Text] [Related]  

  • 71. T-cell antigenic sites of the malaria circumsporozoite protein.
    Good MF; Kumar S; Weiss WR; Miller LH
    Blood; 1989 Aug; 74(3):895-900. PubMed ID: 2665866
    [No Abstract]   [Full Text] [Related]  

  • 72. Differences in malaria vector biting behavior and changing vulnerability to malaria transmission in contrasting ecosystems of western Kenya.
    Nzioki I; Machani MG; Onyango SA; Kabui KK; Githeko AK; Ochomo E; Yan G; Afrane YA
    Parasit Vectors; 2023 Oct; 16(1):376. PubMed ID: 37864217
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Malaria among children under 10 years in 4 endemic health areas in Kisantu Health Zone: epidemiology and transmission.
    Ilombe G; Matangila JR; Lulebo A; Mutombo P; Linsuke S; Maketa V; Mabanzila B; Wat'senga F; Van Bortel W; Fiacre A; Irish SR; Lutumba P; Van Geertruyden JP
    Malar J; 2023 Jan; 22(1):3. PubMed ID: 36604663
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Efficacy of RTS,S/AS01
    Samuels AM; Ansong D; Kariuki SK; Adjei S; Bollaerts A; Ockenhouse C; Westercamp N; Lee CK; Schuerman L; Bii DK; Osei-Tutu L; Oneko M; Lievens M; Attobrah Sarfo MA; Atieno C; Morelle D; Bakari A; Sang T; Jongert E; Kotoh-Mortty MF; Otieno K; Roman F; Buabeng PBY; Ntiamoah Y; Ofori-Anyinam O; Agbenyega T;
    Lancet Infect Dis; 2022 Sep; 22(9):1329-1342. PubMed ID: 35753316
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Adaptive interventions for optimizing malaria control: an implementation study protocol for a block-cluster randomized, sequential multiple assignment trial.
    Zhou G; Lee MC; Atieli HE; Githure JI; Githeko AK; Kazura JW; Yan G
    Trials; 2020 Jul; 21(1):665. PubMed ID: 32690063
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Anopheles arabiensis and Anopheles funestus biting patterns in Dielmo, an area of low level exposure to malaria vectors.
    Doucoure S; Thiaw O; Wotodjo AN; Bouganali C; Diagne N; Parola P; Sokhna C
    Malar J; 2020 Jun; 19(1):230. PubMed ID: 32590996
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Resting behaviour of malaria vectors in highland and lowland sites of western Kenya: Implication on malaria vector control measures.
    Machani MG; Ochomo E; Amimo F; Kosgei J; Munga S; Zhou G; Githeko AK; Yan G; Afrane YA
    PLoS One; 2020; 15(2):e0224718. PubMed ID: 32097407
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Upsurge of malaria transmission after indoor residual spraying withdrawal in Atacora region in Benin, West Africa.
    Aïkpon RY; Padonou G; Dagnon F; Ossè R; Ogouyemi Hounto A; Tokponon F; Aïkpon G; Lyikirenga L; Akogbéto M
    Malar J; 2020 Jan; 19(1):3. PubMed ID: 31900182
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Recombinant measles vaccine expressing malaria antigens induces long-term memory and protection in mice.
    Mura M; Ruffié C; Combredet C; Aliprandini E; Formaglio P; Chitnis CE; Amino R; Tangy F
    NPJ Vaccines; 2019; 4():12. PubMed ID: 30820355
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The impact of long-lasting microbial larvicides in reducing malaria transmission and clinical malaria incidence: study protocol for a cluster randomized controlled trial.
    Zhou G; Wiseman V; Atieli HE; Lee MC; Githeko AK; Yan G
    Trials; 2016 Aug; 17(1):423. PubMed ID: 27558161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.